1-(2-Acetylamino-3-hydroxy-propionyl)-pyrrolidine-2-carboxylic acid amide

ID: ALA107453

Chembl Id: CHEMBL107453

PubChem CID: 14999614

Max Phase: Preclinical

Molecular Formula: C10H17N3O4

Molecular Weight: 243.26

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(N)=O

Standard InChI:  InChI=1S/C10H17N3O4/c1-6(15)12-7(5-14)10(17)13-4-2-3-8(13)9(11)16/h7-8,14H,2-5H2,1H3,(H2,11,16)(H,12,15)/t7-,8-/m0/s1

Standard InChI Key:  ZAMBNSYQLICEOW-YUMQZZPRSA-N

Associated Targets(non-human)

Kallikrein 1 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 243.26Molecular Weight (Monoisotopic): 243.1219AlogP: -2.04#Rotatable Bonds: 4
Polar Surface Area: 112.73Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.21CX Basic pKa: CX LogP: -2.88CX LogD: -2.88
Aromatic Rings: 0Heavy Atoms: 17QED Weighted: 0.53Np Likeness Score: -0.23

References

1. Deshpande MS, Burton J..  (1992)  Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392.,  35  (17): [PMID:1507198] [10.1021/jm00095a002]

Source